OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $857.30 million. The enterprise value is $1.07 billion.
| Market Cap | 857.30M |
| Enterprise Value | 1.07B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 696.99 million shares outstanding. The number of shares has increased by 4.55% in one year.
| Shares Outstanding | 696.99M |
| Shares Change (YoY) | +4.55% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 52.41% |
| Owned by Institutions (%) | 25.07% |
| Float | 331.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.99 |
| Forward PS | 1.11 |
| PB Ratio | 0.62 |
| P/FCF Ratio | n/a |
| PEG Ratio | -2.87 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.55 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.66 |
Financial Efficiency
Return on equity (ROE) is -12.80% and return on invested capital (ROIC) is -9.25%.
| Return on Equity (ROE) | -12.80% |
| Return on Assets (ROA) | -9.00% |
| Return on Capital (ROIC) | -9.25% |
| Revenue Per Employee | $219,719 |
| Profits Per Employee | -$48,057 |
| Employee Count | 3,930 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 7.80 |
Taxes
In the past 12 months, OPKO Health has paid $4.44 million in taxes.
| Income Tax | 4.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.38% in the last 52 weeks. The beta is 1.84, so OPKO Health's price volatility has been higher than the market average.
| Beta (1Y) | 1.84 |
| 52-Week Price Change | -13.38% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 55.71 |
| Average Volume (30 Days) | 9,452,850 |
Short Selling Information
The latest short interest is 93.61 million, so 13.43% of the outstanding shares have been sold short.
| Short Interest | 93.61M |
| Short Previous Month | 102.16M |
| Short % of Shares Out | 13.43% |
| Short % of Float | 28.26% |
| Short Ratio (days to cover) | 7.45 |
Income Statement
In the last 12 months, OPKO Health had revenue of $863.50 million and -$188.86 million in losses. Loss per share was -$0.25.
| Revenue | 863.50M |
| Gross Profit | 318.13M |
| Operating Income | -157.02M |
| Pretax Income | -184.43M |
| Net Income | -188.86M |
| EBITDA | -65.62M |
| EBIT | -170.92M |
| Loss Per Share | -$0.25 |
Balance Sheet
The company has $95.88 million in cash and $308.75 million in debt, giving a net cash position of -$212.87 million or -$0.31 per share.
| Cash & Cash Equivalents | 95.88M |
| Total Debt | 308.75M |
| Net Cash | -212.87M |
| Net Cash Per Share | -$0.31 |
| Equity / Book Value | 1.39B |
| Book Value Per Share | 1.99 |
| Working Capital | 109.42M |
Cash Flow
In the last 12 months, operating cash flow was -$28.20 million and capital expenditures -$13.56 million, giving a free cash flow of -$41.76 million.
| Operating Cash Flow | -28.20M |
| Capital Expenditures | -13.56M |
| Free Cash Flow | -41.76M |
| FCF Per Share | -$0.06 |
Margins
Gross margin is 36.84%, with operating and profit margins of -18.18% and -21.87%.
| Gross Margin | 36.84% |
| Operating Margin | -18.18% |
| Pretax Margin | -21.36% |
| Profit Margin | -21.87% |
| EBITDA Margin | -7.60% |
| EBIT Margin | -19.79% |
| FCF Margin | -4.84% |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.55% |
| Shareholder Yield | -4.55% |
| Earnings Yield | -22.03% |
| FCF Yield | -4.87% |
Analyst Forecast
The average price target for OPKO Health is $3.17, which is 157.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.17 |
| Price Target Difference | 157.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.36 |
| Piotroski F-Score | 2 |